IPO registrations (S-1, F-1) · Registrants

Enlivex Ltd.

SEC CIK
1596812 · filings on EDGAR ↗
Name on the registration
Bioblast Pharma Ltd.
Former names
Enlivex Therapeutics Ltd. (2019–2026); Bioblast Pharma Ltd. (2016–2019); BIO BLAST PHARMA LTD. (2014–2016)
Registration
Form F-1, first filed 2014-02-07, last 2017-04-06; 2 initial registrations, 9 amendments
Outcome
Final prospectus filed 2014-07-31; declared effective 2014-07-30; withdrawal requested 2017-04-06
Industry (SIC)
Finance Services 6199
Incorporated in
L3
Business address
37 DEREH MENACHEM BEGIN ST., 15TH FLOOR, Tel Aviv
Ticker
ENLV (Nasdaq)
EDGAR entity type
other
Insiders and CEO pay
Enlivex Ltd. on the corporate pages

Offering terms

Proposed price range
$11.00–$13.00 per share (F-1/A filed 2014-07-25)
Final price
$11.00 per share, within the range (424B4 filed 2014-07-31, an initial public offering)
Shares sold
3,200,000
Gross proceeds
$35,200,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol ORPN
Lead underwriters
Oppenheimer (1,440,000 shares); Roth Capital Partners (1,440,000 shares)
Syndicate
BTIG (320,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 15

FiledFormWhat it isName as filedEDGAR
2014-02-07F-1F-1 (foreign registration)BIO BLAST PHARMA LTD.0001144204-14-006928 ↗
2014-03-17F-1/AF-1/A (amendment)BIO BLAST PHARMA LTD.0001144204-14-015894 ↗
2014-04-08F-1/AF-1/A (amendment)BIO BLAST PHARMA LTD.0001144204-14-021277 ↗
2014-07-08F-1/AF-1/A (amendment)BIO BLAST PHARMA LTD.0001144204-14-041824 ↗
2014-07-15F-1/AF-1/A (amendment)BIO BLAST PHARMA LTD.0001144204-14-042948 ↗
2014-07-25F-1/AF-1/A (amendment)BIO BLAST PHARMA LTD.0001144204-14-044906 ↗
2014-07-30EFFECTEFFECT (declared effective)BIO BLAST PHARMA LTD.9999999995-14-002300 ↗
2014-07-31424B4424B4 (final prospectus)BIO BLAST PHARMA LTD.0001144204-14-046055 ↗
2015-08-12EFFECTEFFECT (declared effective)BIO BLAST PHARMA LTD.9999999995-15-002277 ↗
2017-02-24F-1F-1 (foreign registration)Bioblast Pharma Ltd.0001144204-17-011003 ↗
2017-03-16F-1/AF-1/A (amendment)Bioblast Pharma Ltd.0001144204-17-014840 ↗
2017-04-04F-1/AF-1/A (amendment)Bioblast Pharma Ltd.0001144204-17-018878 ↗
2017-04-05F-1/AF-1/A (amendment)Bioblast Pharma Ltd.0001144204-17-019259 ↗
2017-04-06F-1/AF-1/A (amendment)Bioblast Pharma Ltd.0001144204-17-019315 ↗
2017-04-06RWRW (withdrawal request)Bioblast Pharma Ltd.0001144204-17-019411 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2014-07-25F-1/Aregistration statement$11.00–$13.00$6.073,333,333$20,233,331Nasdaq ORPN3primary document; range, price sentence, shares headline, proceeds computed, cover names 3document ↗
2014-07-31424B4final prospectus$11.003,200,000$35,200,000Nasdaq ORPN3primary document; price sentence, shares sentence, proceeds table, underwriting table 3, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Galamidi EinatOfficerChief Medical Officer12026
Hart GiliDirector12026
Havron AvrahamDirector12026
Hershkovitz OrenOfficerChief Executive Officer12026
NOVIK SHAI ADirector12026
Pomerantz RogerDirector12026
Shlosberger ShacharOfficerChief Financial Officer12026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2016-04-01BIO BLAST PHARMA LTD.Pharmaceuticals$6,699,999$6,699,99941
2014-02-13BIO BLAST PHARMA LTD.Pharmaceuticals$4,750,000$4,750,000281

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerBIO BLAST PHARMA LTD.CTForm D private offeringsCIK (EXACT)
SEC filerEnlivex Ltd.SEC filers (EDGAR)CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Finance Services:

More with this interest.

Interests: Finance Services · Finance